Klinische Studien über die Anwendung von Roxatidinacetat in der Behandlung des Ulcus pepticum in Japan
- 1 January 1988
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 35 (3), 114-119
- https://doi.org/10.2165/00003495-198800353-00020
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Antisecretory effects of two new histamine H2-receptor antagonists.1986
- Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.1985
- Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).1985
- A Study of the Relationship Between Serum Group I Pepsinogen Levels and Gastric Acid SecretionGastroenterology, 1975